8-K current report · filed Nov 3, 2026

RxSight, Inc. (RXST) 8-K Current Report: November 3, 2026

Item 2.02Item EX-99.1RXST overview

Short answer

RxSight, Inc. (RXST) filed an 8-K current report with the SEC on November 3, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q3 2026 results announcement for the three months ended September 30, 2026.

RxSight, Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Q3 2026 results announcement for the three months ended September 30, 2026
  • Detailed financial results and operating metrics available in Exhibit 99.1
  • Investor focus: quarterly performance, liquidity, and outlook in the attached release

Item EX-99.1 · Exhibit EX-99.1

  • Q3 revenue $24.6M, down 19% YoY, signaling intensified competitive pressure and weaker near-term demand
  • LAL volume 23,128 units, while Alcon collaboration revenue was only $40K during the quarter
  • Gross margin fell to 73.6% from 79.9%, pressured by inventory reserves and higher LAL and LDD costs
  • GAAP net loss widened to $16.2M, or $0.39 per share, from $9.8M, or $0.24 per share
  • Liquidity totaled $254.7M, including $60M from Alcon, supporting commercial expansion and restructuring execution

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other RxSight, Inc. 8-K filings

Get the next RXST 8-K as it lands

Follow RXST for push alerts, or ask the research agent what this filing means.